Prolonged-release melatonin for the treatment of insomnia in patients over 55 years

Bibliography

• Dement WC, Miles LE, Carskadon MA. “White paper” on sleep and aging. J Am Geriatr Soc 1982;30(1):25-50
   PubMed Web of Science ®Google Scholar
• Monane M. Insomnia in the elderly. J Clin Psychiatry 1992;53(Suppl):23-8
   PubMed Web of Science ®Google Scholar
• Morphy H, Dunn KM, Lewis M, et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007;30(3):274-80
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association TFoD-I: Task Force on DSM-IV. In: Diagnostic and statistical manual of mental disorders. 4th edition. Text revision (DSM-IV-TR). Washington DC: American Psychiatric Association; 2000
   Google Scholar
• Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone 2003;5(3):5-15
   PubMedGoogle Scholar
• DSM-IV APA. Diagnostic and statistical manual of mental disorders – DSM-IV. 4th edition. Washington DC; 1994
   Google Scholar
• ICD-10 WHO. Tenth revision of the international classification of diseases. Chapter V (F). Mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva 182/184: WHO; 1992
   Google Scholar
• Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999;22(Suppl 2):S354-8
   PubMed Web of Science ®Google Scholar
• Leger D, Guilleminault C, Deframce R, et al. Prevalence of sleep/wake disorders in persons with blindness. Clin Sci 1999;97:193-9
   PubMed Web of Science ®Google Scholar
• Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64 – 99 years. J Am Geriatr Soc 2000;48(10):1234-40
   PubMed Web of Science ®Google Scholar
• Metlaine A, Leger D, Choudat D. Socioeconomic impact of insomnia in working populations. Ind Health 2005;43(1):11-9
   PubMed Web of Science ®Google Scholar
• Avidan AY, Fries BE, James ML, et al. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005;53(6):955-62
   PubMed Web of Science ®Google Scholar
• Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30(3):263-73
   PubMed Web of Science ®Google Scholar
• Hajak G. Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 2001;251(2):49-56
   PubMed Web of Science ®Google Scholar
• Riemann DFJ, Mayer G, Peter JH. The Guidelines for “Non-Restorative Sleep”: relevance for the diagnosis and therapy of insomnia. Somnologie 2003;7(2):66-76
   Google Scholar
• Szabadi E. Drugs for sleep disorders: mechanisms and therapeutic prospects. Br J Clin Pharmacol 2006;61(6):761-6
   PubMed Web of Science ®Google Scholar
• Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;19(331):1169-76
   Google Scholar
• Krystal AD. Treating the health, quality of life, and functional impairments in insomnia. J Clin Sleep Med 2007;3(1):63-72
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991;79(1-3):C153-8
   PubMed Web of Science ®Google Scholar
• Witt-Enderby PA, Bennett J, Jarzynka MJ, et al. Melatonin receptors and their regulation; biochemical and structural mechanisms. Life Sci 2003;72(20):2183-98
   PubMed Web of Science ®Google Scholar
• Zisapel N, Tarrasch R, Laudon M. The relationship between melatonin and cortisol rhythms: clinical implications of melatonin therapy. Drug Dev Res 2005;65(3):119-25
   Web of Science ®Google Scholar
• Zisapel N. Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci 2007;64(10):1174-86
   PubMed Web of Science ®Google Scholar
• Nair NPV, Hariharasubramanian N, Pilapil C, et al. Plasma melatonin – an index of brain aging in humans? Biol Psychiatry 1986;21:141-50
   PubMed Web of Science ®Google Scholar
• Waldhauser F, Waldhauser M, Lieberman HR, et al. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984;39(4):307-13
   PubMed Web of Science ®Google Scholar
• Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005;9(1):25-39
   PubMed Web of Science ®Google Scholar
• Arendt J. Melatonin and the mammalian pineal gland. London: Chapman & Hall; 1995
   Google Scholar
• EMEA: Circadin EPA Report. 2007. Available from: http://www.emea.europa.eu/humandocs/PDFs/EPAR/circadin/H-695-en6.pdf
   Google Scholar
• Haimov I, Lavie P, Laudon M, et al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18(7):598-603
   PubMed Web of Science ®Google Scholar
• Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995;346(8974):541-4
   PubMed Web of Science ®Google Scholar
• Wurtman RJ, Zhdanova I. Improvement of sleep quality by melatonin. Lancet 1995;346(8988):1491
   PubMed Web of Science ®Google Scholar
• Hughes RJ, Sack R, Lewy A. The role of melatonin and circadian Phase In age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep 1998;21(1):52-68
   PubMed Web of Science ®Google Scholar
• Leger D, Laudon M, Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 2004;116(2):91-5
   PubMed Web of Science ®Google Scholar
• Karasek M. Melatonin, human aging, and age-related diseases. Exp Gerontol 2004;39(11-12):1723-9
   PubMed Web of Science ®Google Scholar
• Jean-Louis G, Kripke DF, Ancoli-Israel S. Sleep and quality of well-being. Sleep 2000;23(8):1115-21
   PubMed Web of Science ®Google Scholar
• Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 2005;20(12):1151-8
   PubMed Web of Science ®Google Scholar
• Brzezinski A, Vangel MG, Wurtman RJ, et al. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 2005;9(1):41-50
   PubMed Web of Science ®Google Scholar
• Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007;16:372-80
   PubMed Web of Science ®Google Scholar
• Wade A, Ford I, Crawford G, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin 2007;23:2597-605
   PubMed Web of Science ®Google Scholar
• Tarrasch R, Laudon M, Zisapel N. Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients. Hum Psychopharmacol 2003;18(8):603-10
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Ancli-Israel S, Edinger JD, et al. Recommendations for a standard research assessment of insomnia. Sleep 2006;29(9):1155-76
   PubMed Web of Science ®Google Scholar
• Otmani S, Demazieres A, Staner C, et al. Effects of prolonged-release melatonin, zolpidem and their combination on psychomotor functions, memory recall and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol 2008 [Epub ahead of print]
   Google Scholar
• Garfinkel D, Laudon M, Zisapel N. Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs. Arch Gerontol Geriatr 1997;24(2):223-31
   PubMed Web of Science ®Google Scholar
• Buscemi N, Vandermeer B, Hooton N, et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 2006;332(7538):385-93
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28(2):193-213
   PubMed Web of Science ®Google Scholar
• Tekbas OF, Ogur R, Korkmaz A, et al. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J Pineal Res 2008;44(2):222-6
   PubMed Web of Science ®Google Scholar
• Ayer RE, Sugawara T, Chen W, et al. Melatonin decreases mortality following severe subarachnoid hemorrhage. J Pineal Res 2008;44(2):197-204
   PubMed Web of Science ®Google Scholar